Sirona Biochem Corp V.SBM

Alternate Symbol(s): SRBCF

Healthcare Biotechnology

Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.

TSXV:SBM - Post by User

Sirona Biochem Corp

Bullboard Posts

Comment by zerboon Jun 29, 2015 11:01am

113 Views

Post# 23876902

RE:News...Patent granted

appointment of Mr. Casper Bych to its Board of Directors.
Mr. Bych has more than 20 years' experience in management and in the legal and financial industry in Europe, South and North America. Casper is the President and CEO of Mountainview Capital Corporation
...Mountainview Capital also provides financial advisory services in connection with project financings and acts as management consultant for companies in the process of going public or undergoing M&A transactions.

Bullboard Posts

Invest wiser with BMO's InvestorLine Platform features